NN Inc. Q1 revenue $105.7M (-12.8% YoY); adj. EPS $(0.03) vs $(0.08); raises 5-yr EBITDA margin target to 13-14%

NN INC

2025-Q1 EPS reported -$0.23 revenue$105,688,000

Q1 net sales $105.7M, down 12.8% YoY; GAAP EPS $(0.23), adjusted EPS $(0.03) improved from $(0.34) and $(0.08) in prior year.
Pro forma adjusted EBITDA $10.6M (flat YoY); margin 10% vs 9.3% in Q1 2024; adj. operating income $2.0M vs ($0.7M).
FY 2025 guidance: net sales $430-460M; adj. EBITDA $53-63M; initiating free cash flow guidance of $14-16M.
Raised 5-year adjusted EBITDA margin target to 13-14%; expects $15M cost savings in 2025; new business wins $16.4M in Q1.
Term loan refinancing completed post-quarter; tariff impact immaterial; medical pipeline at peak $40M+.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.